glp 1 agonists and anesthesia GLP-1 Anesthesia: Considerations and Cautions for CRNAs ASA Advises No Longer Holding
Description
Rodgers RJ, Tschp MH, Wilding JP
In our Medicaid study, we manually reviewed each states prior authorization policy and found that most were more restrictive than FDA criteria for the drugs
TRIUMPH-1: A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight (TRIUMPH-1)
SK approved the final manuscript submitted
A similar study reported that berberine treatment significantly elevates the number of GLP-1 positive L cells in mice
Other common side effects include headaches, injection site reactions, and nasopharyngitis, but these do not usually result in discontinuation of the drug [74-77]
